Skip to main content

Advertisement

Log in

Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report

  • Original Paper
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Purpose

Down-regulated expression of the putative tumor suppressor gene spleen tyrosine kinase (SYK) is strongly associated with the development of various cancers, including colorectal cancer (CRC). SYK gene promoter polymorphisms have been shown to be involved in the pathogenesis of multiple malignant tumors. In this study, we investigated associations of SYK gene promoter polymorphisms with the susceptibility to colorectal cancer development in a Southern Han Chinese population.

Methods

SNPs in the promoter region of the human SYK gene were identified using in silico analysis tools, linkage disequilibrium analysis, and a search for likely transcription factor binding sites via TFSEARCH in the NCBI SNP database (gene ID: 6850). Based on this information, −803A > T and −534T > C were selected as candidates for further analysis. TaqMan-MGB probe analyses were performed in 567 CRC patients and 569 age- and gender-matched healthy controls for SYK gene promoter genotyping. Associations between CRC risk and SNPs were estimated using an unconditional logistic regression model, and environmental risk factors were included in a multivariate logistic regression model for correction.

Results

The frequencies of the TA and TT genotypes and the T allele of the –803A > T SNP were found to be significantly higher in the CRC patients compared to the healthy individuals of the control group (P = 0.020, 0.023, and 0.013, respectively). Synergistic effects between –803A > T genotypes (i.e., TA + TT) and age (≤60 years; P = 0.039), male gender (P = 0.011), smoking (P = 0.005), drinking alcohol (P = 0.002), and high BMI (≥24.0 kg/m2; P = 0.009) were found to increase the risk to develop CRC by stratified analyses.

Conclusions

The SYK −803 A > T genotypes TA and TT are independent risk factors for CRC development in Han Chinese in Southern China, and an association with TA + TT genotypes appears predominant among younger patients, male patients, patients with a high BMI, and patients who smoke or drink alcohol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. T. Cacev, G. Aralica, B. Loncar, S. Kapitanovic, Loss of NF2/Merlin expression in advanced sporadic colorectal cancer. Cell. Oncol. 37, 69–77 (2014)

    Article  CAS  Google Scholar 

  2. S.D. Markowitz, M.M. Bertagnolli, Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449–2460 (2009)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Z. Yang, L. Huo, H. Chen, B. Ni, J. Xiang, L. Kang, L. Wang, J. Peng, Y. Yuan, J. Wang, Hypermethylation and prognostic implication of Syk gene in human colorectal cancer. Med. Oncol. 30, 586 (2013)

    Article  PubMed  Google Scholar 

  4. L. Duan, L. Ye, G. Zhao, Z. Wu, C. Jin, X. Cai, G. Li, Serum spleen tyrosine kinase and vascular endothelial growth factor-C levels predict lymph node metastasis of oesophageal squamous cell carcinoma. Eur. J. Cardiothorac. Surg.: Off. J. Eur. Asso. Cardiothorac. Surg. 43, e58–63 (2013)

    Article  Google Scholar 

  5. S. Luangdilok, C. Box, L. Patterson, W. Court, K. Harrington, L. Pitkin, P. Rhys-Evans, P. O-charoerat, S. Eccles, Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res. 67, 7907–7916 (2007)

    Article  CAS  PubMed  Google Scholar 

  6. U. Inayat, M.A. Kayani, R. Faryal, Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report. Polish J. Path.: Off. J. Polish Soc. Path. 63, 106–111 (2012)

    CAS  Google Scholar 

  7. C. Peng, Q. Sun, Y. Hao, B. Cong, Y. Zhao, X. Zhao, Syk is low-expressed in non-small-cell lung cancer and inversely correlates with patient’s survival. Acta Biochim. Biophys. Sin. 45, 149–151 (2013)

    Article  PubMed  Google Scholar 

  8. L. Wang, E. Devarajan, J. He, S.P. Reddy, J.L. Dai, Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression. Cancer Res. 65, 10289–10297 (2005)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. O. Bailet, N. Fenouille, P. Abbe, G. Robert, S. Rocchi, N. Gonthier, C. Denoyelle, M. Ticchioni, J.P. Ortonne, R. Ballotti, M. Deckert, S. Tartare-Deckert, Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Res. 69, 2748–2756 (2009)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. T. Layton, C. Stalens, F. Gunderson, S. Goodison, S. Silletti, Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion. Am. J. Pathol. 175, 2625–2636 (2009)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. S. Ogane, T. Onda, N. Takano, T. Yajima, T. Uchiyama, T. Shibahara, Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma. Int. J. Cancer. J. Int. du Cancer 124, 2651–2657 (2009)

    Article  CAS  Google Scholar 

  12. A. Yousuf, M.Y. Bhat, A.A. Pandith, D. Afroze, N.P. Khan, K. Alam, P. Shah, M.A. Shah, S. Mudassar, MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell. Oncol. 37, 245–252 (2014)

    Article  CAS  Google Scholar 

  13. J.S. de Groot, X. Pan, J. Meeldijk, E. van der Wall, P.J. van Diest, C.B. Moelans, Validation of DNA promoter hypermethylation biomarkers in breast cancer–a short report. Cell. Oncol. 37, 297–303 (2014)

    Article  Google Scholar 

  14. E. Yiannakopoulou, Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents–implications for cancer treatment and chemoprevention. Cell. Oncol. 37, 167–178 (2014)

    Article  CAS  Google Scholar 

  15. M. Sabir, R.M. Baig, K. Ali, I. Mahjabeen, M. Saeed, M.A. Kayani, Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer. Cell. Oncol. 37, 203–213 (2014)

    Article  CAS  Google Scholar 

  16. B. Bessenyei, M. Marka, L. Urban, M. Zeher, I. Semsei, Single nucleotide polymorphisms: aging and diseases. Biogerontology 5, 291–303 (2004)

    Article  CAS  PubMed  Google Scholar 

  17. L. Ma, S. Dong, P. Zhang, N. Xu, H. Yan, H. Liu, Y. Li, Q. Zhou, The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer. Clin. Lab. 56, 407–416 (2010)

    CAS  PubMed  Google Scholar 

  18. C. Yan, C. Liu, Q. Jin, Z. Li, B. Tao, Z. Cai, The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines. Oncol. Lett. 4, 505–508 (2012)

    PubMed Central  CAS  PubMed  Google Scholar 

  19. N.A. Mundell, J.L. Plank, A.W. LeGrone, A.Y. Frist, L. Zhu, M.K. Shin, E.M. Southard-Smith, P.A. Labosky, Enteric nervous system specific deletion of Foxd3 disrupts glial cell differentiation and activates compensatory enteric progenitors. Dev. Biol. 363, 373–387 (2012)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. A.S. Cheng, M.S. Li, W. Kang, V.Y. Cheng, J.L. Chou, S.S. Lau, M.Y. Go, C.C. Lee, T.K. Ling, E.K. Ng, J. Yu, T.H. Huang, K.F. To, M.W. Chan, J.J. Sung, F.K. Chan, Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology 144, 122–133 (2013). e129

    Article  CAS  PubMed  Google Scholar 

  21. D. Hoffmann, I. Hoffmann, K. El-Bayoumy, The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14, 767–790 (2001)

    Article  CAS  PubMed  Google Scholar 

  22. S. Raimondi, E. Botteri, S. Iodice, A.B. Lowenfels, P. Maisonneuve, Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutat. Res. 670, 6–14 (2009)

  23. A. Pfohl-Leszkowicz, Y. Grosse, V. Carriere, P.H. Cugnenc, A. Berger, F. Carnot, P. Beaune, I. de Waziers, High levels of DNA adducts in human colon are associated with colorectal cancer. Cancer Res. 55, 5611–5616 (1995)

    CAS  PubMed  Google Scholar 

  24. J.N. Poynter, R.W. Haile, K.D. Siegmund, P.T. Campbell, J.C. Figueiredo, P. Limburg, J. Young, L. Le Marchand, J.D. Potter, M. Cotterchio, G. Casey, J.L. Hopper, M.A. Jenkins, S.N. Thibodeau, P.A. Newcomb, J.A. Baron, R. Colon, Cancer family, associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol. Biomarkers Prev. 18, 2745–2750 (2009)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. L.C. Thygesen, K. Wu, M. Gronbaek, C.S. Fuchs, W.C. Willett, E. Giovannucci, Alcohol intake and colorectal cancer: a comparison of approaches for including repeated measures of alcohol consumption. Epidemiology 19, 258–264 (2008)

    Article  PubMed  Google Scholar 

  26. A.T. Toriola, S. Kurl, J.A. Laukanen, C. Mazengo, J. Kauhanen, Alcohol consumption and risk of colorectal cancer: the Findrink study. Eur. J. Epidemiol. 23, 395–401 (2008)

    Article  CAS  PubMed  Google Scholar 

  27. E.M. Siegel, C.M. Ulrich, E.M. Poole, R.S. Holmes, P.B. Jacobsen, D. Shibata, The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control: J. Moffitt Cancer Center 17, 52–57 (2010)

    Google Scholar 

  28. G. Gonullu, H. Kahraman, A. Bedir, A. Bektas, I. Yucel, Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int. J. Color. Dis. 25, 205–212 (2010)

    Article  Google Scholar 

  29. S. Yamamoto, T. Nakagawa, Y. Matsushita, S. Kusano, T. Hayashi, M. Irokawa, T. Aoki, Y. Korogi, T. Mizoue, M. Irokawa, T. Aoki, Y. Korogi, T. Mizoue, Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care 33, 184–189 (2010)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by grants from the National Natural Science Foundation of China (No. 81172040 and 30872488 to Jianping Wang and No. 81072042 to Lei Wang) and the “985 project” of Sun Yat-sen University and the Guangdong Translational Medicine Public Platform (No. 4202037). We thank Jun Hu, Chenliang Wang and Junxiao Zhang for critical review and language editing of this manuscript, as well as Dian-Ke Chen for his technical support.

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jianping Wang.

Additional information

Hui Peng and Jun Huang are contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, H., Huang, J., Hu, Y. et al. Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report. Cell Oncol. 38, 165–172 (2015). https://doi.org/10.1007/s13402-014-0208-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-014-0208-2

Keywords

Navigation